Annual Retained Earnings
-$1.37 B
-$366.25 M-36.64%
December 31, 2024
Summary
- As of March 10, 2025, CRSP annual retained earnings is -$1.37 billion, with the most recent change of -$366.25 million (-36.64%) on December 31, 2024.
- During the last 3 years, CRSP annual retained earnings has fallen by -$1.17 billion (-597.22%).
- CRSP annual retained earnings is now -16155.53% below its all-time high of -$8.40 million, reached on December 31, 2014.
Performance
CRSP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.37 B
-$37.31 M-2.81%
December 31, 2024
Summary
- As of March 10, 2025, CRSP quarterly retained earnings is -$1.37 billion, with the most recent change of -$37.31 million (-2.81%) on December 31, 2024.
- Over the past year, CRSP quarterly retained earnings has dropped by -$123.25 million (-9.92%).
- CRSP quarterly retained earnings is now -1984.44% below its all-time high of $72.49 million, reached on June 30, 2021.
Performance
CRSP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CRSP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.6% | -9.9% |
| 3 y3 years | -597.2% | -9.9% |
| 5 y5 years | -507.9% | -9.9% |
CRSP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -597.2% | at low | -597.2% | at low |
| 5 y | 5-year | -597.2% | at low | -1984.4% | at low |
| alltime | all time | <-9999.0% | at low | -1984.4% | at low |
CRISPR Therapeutics AG Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$1.37 B(+36.6%) | -$1.37 B(+2.8%) |
| Sep 2024 | - | -$1.33 B(+6.9%) |
| Jun 2024 | - | -$1.24 B(+11.3%) |
| Mar 2024 | - | -$1.12 B(+11.7%) |
| Dec 2023 | -$999.70 M(+18.2%) | -$999.70 M(-8.2%) |
| Sep 2023 | - | -$1.09 B(+11.5%) |
| Jun 2023 | - | -$976.89 M(+8.6%) |
| Mar 2023 | - | -$899.15 M(+6.3%) |
| Dec 2022 | -$846.09 M(+331.9%) | -$846.09 M(+15.0%) |
| Sep 2022 | - | -$735.51 M(+31.1%) |
| Jun 2022 | - | -$560.97 M(+49.5%) |
| Mar 2022 | - | -$375.13 M(+91.5%) |
| Dec 2021 | -$195.91 M(-65.8%) | -$195.91 M(+258.4%) |
| Sep 2021 | - | -$54.67 M(-175.4%) |
| Jun 2021 | - | $72.49 M(-110.6%) |
| Mar 2021 | - | -$686.74 M(+19.7%) |
| Dec 2020 | -$573.58 M | -$573.58 M(+22.9%) |
| Sep 2020 | - | -$466.54 M(+24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -$374.10 M(+27.1%) |
| Mar 2020 | - | -$294.44 M(+31.0%) |
| Dec 2019 | -$224.71 M(-22.9%) | -$224.71 M(-12.0%) |
| Sep 2019 | - | -$255.25 M(-35.2%) |
| Jun 2019 | - | -$393.68 M(+15.8%) |
| Mar 2019 | - | -$339.98 M(+16.6%) |
| Dec 2018 | -$291.57 M(+132.4%) | -$291.57 M(+19.5%) |
| Sep 2018 | - | -$243.98 M(+26.2%) |
| Jun 2018 | - | -$193.27 M(+24.8%) |
| Mar 2018 | - | -$154.89 M(+23.5%) |
| Dec 2017 | -$125.44 M(+119.8%) | -$125.44 M(-0.1%) |
| Sep 2017 | - | -$125.58 M(+24.5%) |
| Jun 2017 | - | -$100.87 M(+28.4%) |
| Mar 2017 | - | -$78.56 M(+37.6%) |
| Dec 2016 | -$57.08 M(+68.4%) | -$57.08 M(-23.1%) |
| Sep 2016 | - | -$74.18 M(+24.2%) |
| Jun 2016 | - | -$59.72 M(+76.1%) |
| Dec 2015 | -$33.91 M(+303.5%) | -$33.91 M |
| Dec 2014 | -$8.40 M | - |
FAQ
- What is CRISPR Therapeutics AG annual retained earnings?
- What is the all time high annual retained earnings for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual retained earnings year-on-year change?
- What is CRISPR Therapeutics AG quarterly retained earnings?
- What is the all time high quarterly retained earnings for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly retained earnings year-on-year change?
What is CRISPR Therapeutics AG annual retained earnings?
The current annual retained earnings of CRSP is -$1.37 B
What is the all time high annual retained earnings for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual retained earnings is -$8.40 M
What is CRISPR Therapeutics AG annual retained earnings year-on-year change?
Over the past year, CRSP annual retained earnings has changed by -$366.25 M (-36.64%)
What is CRISPR Therapeutics AG quarterly retained earnings?
The current quarterly retained earnings of CRSP is -$1.37 B
What is the all time high quarterly retained earnings for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly retained earnings is $72.49 M
What is CRISPR Therapeutics AG quarterly retained earnings year-on-year change?
Over the past year, CRSP quarterly retained earnings has changed by -$123.25 M (-9.92%)